|Articles|November 2, 2002

Pharmaceutical Technology-11-02-2002
Volume 26
Issue 11

Major Changes Ahead for FDA

FDA is juggling momentous changes, including new leadership and the proposed transfer of oversight for therapeutic biotech drugs.

External Link - article-40954.pdf

Articles in this issue

almost 24 years ago

Article

Contract Services

almost 24 years ago

Article

Estimation of Distribution Coefficients from the Partition Coefficient and pKa

almost 24 years ago

Article

Residual Solvent Analysis in Pharmaceuticals

almost 24 years ago

Article

Preparation and In Vitro Evaluation of Miconazole Nitrate-Loaded Topical Liposomes

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance. Subscribe to Pharmaceutical Technology and never miss an industry breakthrough.

Subscribe

Related Content

Europe Map with virtual gavel and sound block and AI word. Concept of the EU recently adopted the AI Act, ushering in new restrictions on Artificial Intelligence use cases and mandating transparency | Image Credit: ©tanaonte -stock.adobe.com

Europe Tried to Ban Generative AI From Critical GMP. The Ban May Not Survive. It Does Not Matter.

ByBrian Drapeau

August 13th 2026

Glenn Herring, Technical Operations Consultant, Halo

Inside Halo’s New Fill-Finish Platform

ByGlenn Herring,Zachary Zubulake

August 12th 2026

Three Formats, One Platform: Halo's New Sterile Fill-Finish Line

ByLee Karras,Zachary Zubulake

August 11th 2026

Pharma's AI ROI Problem Isn't a Tech Problem but a Qualification Problem

ByBrian Drapeau

August 10th 2026

PharmTech Weekly Roundup—August 7, 2026

BySusan Haigney

August 7th 2026

Major Changes Ahead for FDA

Articles in this issue

Related Content

Europe Tried to Ban Generative AI From Critical GMP. The Ban May Not Survive. It Does Not Matter.

Inside Halo’s New Fill-Finish Platform

Three Formats, One Platform: Halo's New Sterile Fill-Finish Line

Pharma's AI ROI Problem Isn't a Tech Problem but a Qualification Problem

PharmTech Weekly Roundup—August 7, 2026

Trending on Pharmaceutical Technology

Pharma's AI ROI Problem Isn't a Tech Problem but a Qualification Problem

Danish Biotechs Attracting Investor Attention

Europe Tried to Ban Generative AI From Critical GMP. The Ban May Not Survive. It Does Not Matter.

Inside Halo’s New Fill-Finish Platform

Q&A: AI Coding Tools Carry the Real Risk